BAMOMAB GmbH, established in 2006, specializes in providing high-quality reagents for immunological research. These reagents include novel monoclonal antibodies and ELISA kits developed in collaboration with the Department of Immunology at the University of Tübingen.
Product Offerings:
- Monoclonal Antibodies: BAMOMAB offers antibodies targeting MICA and MICB proteins, such as:
- BAMO1: Recognizes both MICA and MICB proteins.
- AMO1: Specific to MICA.
- BMO2: Specific to MICB.
- ELISA Kits: The company provides sandwich ELISA kits designed for the detection of soluble MICA (sMICA), facilitating research in immunology and related fields
